Valuation AFT Pharmaceuticals Limited

Stocks

End-of-day quote New Zealand S.E. 28/08/2026			5-day change	1st Jan Change
4.500 ^NZD	+4.17%		+1.81%	+33.14%

07-31	AFT Pharmaceuticals Limited - Shareholder/Analyst Call
07-31	New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	378	362.8	328.2	282.1	352.4	471.9	-	-
Change	-	-4%	-9.54%	-14.06%	24.91%	33.94%	-	-
Enterprise Value (EV) ¹	407.3	392.7	344.4	296.6	391	501.8	496.5	492.1
Change	-	-3.57%	-12.3%	-13.89%	31.82%	28.35%	-1.04%	-0.9%
P/E	19x	34.6x	20.9x	24.5x	24x	24x	19x	17.8x
PBR	6.66x	4.95x	3.74x	2.89x	3.2x	5.16x	4.3x	3.55x
PEG	-	-0.7x	0.4x	-0.9x	0.9x	0.7x	0.7x	2.52x
Capitalization / Revenue	2.9x	2.32x	1.68x	1.36x	1.38x	1.55x	1.37x	1.2x
EV / Revenue	3.13x	2.51x	1.76x	1.43x	1.53x	1.65x	1.44x	1.25x
EV / EBITDA	19x	18.4x	13.1x	14.2x	13.6x	14.5x	12x	9.86x
EV / EBIT	20x	20x	14.2x	16.8x	16x	16.4x	13.4x	10.9x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.016	0.018	0.025	0.0328	0.0416	0.0652
Rate of return	-	-	0.51%	0.67%	0.74%	0.73%	0.92%	1.45%
EPS ²	0.19	0.1	0.15	0.11	0.14	0.1878	0.2366	0.2533
Distribution rate	-	-	10.7%	16.4%	17.9%	17.4%	17.6%	25.7%
Net sales ¹	130.3	156.6	195.4	208	254.7	303.8	345.2	392.5
EBITDA ¹	21.43	21.39	26.25	20.88	28.8	34.63	41.41	49.9
EBIT ¹	20.39	19.67	24.24	17.65	24.44	30.64	37.05	45.17
Net income ¹	19.85	10.65	15.61	11.96	14.73	19.7	24.81	26.56
Net Debt ¹	29.3	29.9	16.2	14.5	38.6	29.84	24.6	20.14
Reference price ²	3.610	3.460	3.130	2.690	3.360	4.500	4.500	4.500
Nbr of stocks (in thousands)	104,697	104,866	104,866	104,866	104,866	104,875	-	-
Announcement Date	22/05/22	22/05/23	22/05/24	21/05/25	20/05/26	-	-	-

¹NZD in Million²NZD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AFT PHARMACEUTICALS LIMITED	23.96x	1.65x	14.49x	0.73%	280M
ELI LILLY AND COMPANY	33.44x	12.14x	24.6x	0.59%	1,047B
JOHNSON & JOHNSON	29.82x	-	-	2%	646B
ABBVIE INC.	32.61x	7.57x	15.74x	2.68%	451B
ROCHE HOLDING AG	19.99x	4.75x	11.76x	2.79%	355B
NOVARTIS AG	21.76x	5.62x	13.93x	2.85%	291B
ASTRAZENECA PLC	20.88x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.35x	7.07x	12.56x	2.33%	234B
NOVO NORDISK A/S	13.25x	4.77x	9.95x	3.83%	203B
GILEAD SCIENCES, INC.	-44.51x	6.43x	25.11x	2.26%	181B
Average	17.85x	6.03x	15.60x	2.21%	365.96B
Weighted average by Cap.	24.24x	8.07x	17.81x	1.97%